Plaque T-cell activity: Not so specific?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 7, 2001, Pages 1099-1101

  Stemme, Sten ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROSIS; CELLULAR IMMUNITY; EDITORIAL; IMMUNE SYSTEM; INFLAMMATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035722188     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0701.093687     Document Type: Editorial

References (43)

1. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque
2. Human atherosclerosis, II: Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions
3. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E - Deficient mice
4. Polyclonal origin of T lymphocytes in human atherosclerotic plaques
5. Diversity of T-cell antigen receptor Vb gene utilization in advanced human atheroma
6. T lymphocytes from human atherosclerotic plaques recognize oxidized LDL
7. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65
8. Unstable atherosclerotic plaques contain T-cells that respond to Chlamydia pneumoniae
9. T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens
10. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery
11. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis
12. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits
13. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits
14. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice
15. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis
16. Immunization of LDL receptor-deficient mice with homologous malondialdehydemodified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes
17. Atherosclerosis: Cell biology and lipoproteins
18. Interleukin-15 expression in atherosclerotic plaques: An alternative pathway for T-cell activation in atherosclerosis?
19. Title
20. Cloning of a T cell growth factor that interacts with the β-chain of the interleukin-2 receptor
21. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc γ2a protein blocks delayed-type hypersensitivity
22. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen-induced immunopathology
23. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis
24. IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-γ secretion by CD4+ T cells in the absence of TCR ligation
25. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes
26. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: Evidence for differential receptor subunit utilization associated with stimulation or inhibition
27. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis
28. Chemoattraction of human blood T lymphocytes by interleukin-15
29. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo
30. IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels
31. Interleukin 15: A proinflammatory role in rheumatoid arthritis synovitis
32. The NF-κB binding site is essential for transcriptional activation of the IL-15 gene
33. Interleukin-15 (IL-15) induces NF-κB activation and IL-8 production in human neutrophils
34. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production
35. Antigen-specific development of primary and memory T cells in vivo
36. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1
37. Antigen-independent activation of naive and memory resting T cells by a cytokine combination
38. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: Role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production
39. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
40. Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo
41. Requirement for CD44 in activated T cell extravasation into an inflammatory site
42. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion
43. Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment